183 related articles for article (PubMed ID: 35106916)
1. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
DuBrock HM; Del Valle KT; Krowka MJ
Liver Transpl; 2022 Jul; 28(7):1224-1230. PubMed ID: 35106916
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
Jose A; Shah SA; Anwar N; Jones CR; Sherman KE; Elwing JM
Liver Transpl; 2021 Dec; 27(12):1811-1823. PubMed ID: 33964116
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Portopulmonary Hypertension.
DuBrock HM; Cartin-Ceba R; Channick RN; Kawut SM; Krowka MJ
Chest; 2021 Jan; 159(1):328-336. PubMed ID: 32798521
[TBL] [Abstract][Full Text] [Related]
5. Portopulmonary hypertension: Results from a 10-year screening algorithm.
Krowka MJ; Swanson KL; Frantz RP; McGoon MD; Wiesner RH
Hepatology; 2006 Dec; 44(6):1502-10. PubMed ID: 17133488
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure ≥35 mm Hg.
DuBrock HM; Runo JR; Sadd CJ; Burger CD; Cartin-Ceba R; Rosen CB; Taner T; Nyberg SL; Heimbach JK; Findlay JY; Krowka MJ
Transplant Direct; 2020 Dec; 6(12):e630. PubMed ID: 33204828
[TBL] [Abstract][Full Text] [Related]
7. Portopulmonary hypertension: an update.
Safdar Z; Bartolome S; Sussman N
Liver Transpl; 2012 Aug; 18(8):881-91. PubMed ID: 22674534
[TBL] [Abstract][Full Text] [Related]
8. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
[TBL] [Abstract][Full Text] [Related]
9. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
DuBrock HM
Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
Savale L; Sattler C; Coilly A; Conti F; Renard S; Francoz C; Bouvaist H; Feray C; Borentain P; Jaïs X; Montani D; Parent F; O'Connell C; Hervé P; Humbert M; Simonneau G; Samuel D; Calmus Y; Duvoux C; Durand F; Duclos-Vallée JC; Sitbon O
Hepatology; 2017 May; 65(5):1683-1692. PubMed ID: 27997987
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.
Krowka MJ; Plevak DJ; Findlay JY; Rosen CB; Wiesner RH; Krom RA
Liver Transpl; 2000 Jul; 6(4):443-50. PubMed ID: 10915166
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival in portopulmonary hypertension: a 20-year experience.
Aggarwal M; Li M; Bhardwaj A; Wallace WD; Wang X; Carey WD; Dweik RA; Heresi GA; Tonelli AR
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):449-456. PubMed ID: 34907982
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.
Salgia RJ; Goodrich NP; Simpson H; Merion RM; Sharma P
Dig Dis Sci; 2014 Aug; 59(8):1976-82. PubMed ID: 24557576
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension.
Cartin-Ceba R; Burger C; Swanson K; Vargas H; Aqel B; Keaveny AP; Heimbach J; Taner T; Nyberg S; Rosen C; Cajigas H; DuBrock H; Krowka MJ
Transplantation; 2021 Oct; 105(10):2283-2290. PubMed ID: 33065725
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal membrane oxygenation rescue therapy in a case of portopulmonary hypertension during liver transplantation: a case report.
Stratta C; Lavezzo B; Ballaris MA; Panio A; Crucitti M; Andruetto P; Fanelli V; Grosso Marra W; Ranieri MV; Salizzoni M
Transplant Proc; 2013 Sep; 45(7):2774-5. PubMed ID: 24034045
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
Krowka MJ; Wiesner RH; Heimbach JK
J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes.
Del Valle KT; Krowka MJ; Heimbach JK; Taner T; DuBrock HM
Transplant Direct; 2022 Dec; 8(12):e1410. PubMed ID: 36398194
[TBL] [Abstract][Full Text] [Related]
18. Portopulmonary hypertension.
Krowka MJ
Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
[TBL] [Abstract][Full Text] [Related]
20. Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation.
DeMartino ES; Cartin-Ceba R; Findlay JY; Heimbach JK; Krowka MJ
Transplantation; 2017 Jan; 101(1):101-106. PubMed ID: 28009757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
